Kamlesh Sodani

Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters

Amit K. Tiwari, Kamlesh Sodani, Si‐Rong Wang et al. · Biochemical Pharmacology · 2009 · 207 citations

Molecular Pharmacology, Drug Resistance Analysis, Biochemistry +9

Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models

Amit K. Tiwari, Kamlesh Sodani, Chun-ling Dai et al. · Cancer Letters · 2012 · 138 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Drug Target +12

Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance

Yehong Kuang, Tong Shen, Xiang Chen et al. · Biochemical Pharmacology · 2009 · 98 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Potent Reversal Agents +9

GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance

Kamlesh Sodani, Amit K. Tiwari, Satyakam Singh et al. · Biochemical Pharmacology · 2012 · 61 citations · Full text

Molecular Pharmacology, Tumor Biology, Abcb1-mediated Drug Resistance +13

PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR

Nagaraju Anreddy, Atish Patel, Kamlesh Sodani et al. · Acta Pharmaceutica Sinica B · 2014 · 51 citations · Full text